FDA Drug Application (020868) for FLAGYL ER by GD SEARLE LLC

Back to FDA Applications sponsored by GD SEARLE LLC

Application Number020868
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage750MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameFLAGYL ER
Active IngredientMETRONIDAZOLE

Active IngredientCount
List of drugs with Active Ingredient METRONIDAZOLE19


Back to FDA Applications sponsored by GD SEARLE LLC